A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples